HERON THERAPEUTICS, INC. short interest in 2025
In 2025, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 20.42% of shares outstanding on 15 Jan 2025 to 18.57% on 31 Dec 2025, a change of -1.85 percentage points. The year's high was 24.20% on 30 Jun 2025 and its low 18.05% on 15 Dec 2025, averaging 21.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.05 days on 31 Jul 2025. Full history: HERON THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 20.42% (15 Jan 2025)
- End of year
- 18.57% (31 Dec 2025)
- Change
- -1.85 pp
- High
- 24.20% (30 Jun 2025)
- Low
- 18.05% (15 Dec 2025)
- Average
- 21.18%
- Highest days to cover
- 38.05 (31 Jul 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 20.42% | 21.63 | |
| 31 Jan 2025 | 20.28% | 21.10 | |
| 14 Feb 2025 | 20.20% | 31.79 | |
| 28 Feb 2025 | 20.56% | 9.79 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 21.05% | 14.36 | |
| 31 Mar 2025 | 21.35% | 24.59 | |
| 15 Apr 2025 | 21.64% | 25.73 | |
| 30 Apr 2025 | 21.86% | 33.10 | |
| 15 May 2025 | 22.56% | 11.15 | 10-Q filed, results (8-K) |
| 30 May 2025 | 22.26% | 37.97 | |
| 13 Jun 2025 | 22.42% | 33.81 | |
| 30 Jun 2025 | 24.20% | 19.55 | |
| 15 Jul 2025 | 23.15% | 28.14 | |
| 31 Jul 2025 | 23.00% | 38.05 | |
| 15 Aug 2025 | 21.68% | 10.56 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 21.13% | 18.49 | |
| 15 Sep 2025 | 21.50% | 27.64 | |
| 30 Sep 2025 | 22.42% | 19.12 | |
| 15 Oct 2025 | 21.46% | 23.73 | |
| 31 Oct 2025 | 19.02% | 20.69 | |
| 14 Nov 2025 | 19.96% | 16.24 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 19.61% | 17.10 | |
| 15 Dec 2025 | 18.05% | 15.31 | |
| 31 Dec 2025 | 18.57% | 19.93 |
See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.